Sustained perimacular vascular and visual response to topical beta blockers in normal human eyes

Brain Research Bulletin

Volumn 62, Issue 6, 2004, Pages 529-535

  Sponsel, William E ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Betaxolol; Contrast sensitivity; Intraocular pressure; Neuroprotection; Ocular circulation; Perimetry; Retinal macular circulation; Timolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; TIMOLOL;

ADULT; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; BRAIN MICROCIRCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; LEUKOCYTE; MALE; NORMAL HUMAN; PATIENT SELECTION; PERIMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RETINA MACULA LUTEA; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; VISION;

EID: 1342270080     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00218-1     Document Type: Conference Paper

References (43)

1. Allen R.C., Hertzmark E., Walker A.M., Epstein D.L. A double-masked comparison of betaxolol vs. timolol in the treatment of open-angle glaucoma. Am. J. Ophthalmol. 101:1986;535-541.
2. Altan-Yaycioglu R., Turker G., Akdol S., Acunas G., Izgi B. The effects of beta-blockers on ocular blood flow in patients with primary open angle glaucoma: a color Doppler imaging study. Eur. J. Ophthalmol. 11:2001;37-46.
3. O. Arend, N. Plange, W.E. Sponsel, A. Remky, Pathogenic aspects of the glaucomatous optic neuropathy: fluoroscein angiographic findings in patients with primary open angle glaucoma, Brain Res. Bull. 62 (2003) in press.
4. Berry D.P., Van Buskirk E.M., Shields M.B. Betaxolol and timolol: a comparison of efficacy and side effects. Arch. Ophthalmol. 102:1984;42-45.
5. Bessho H., Suzuki J., Kitada Y., Narimatsu A., Tobe A. Antihypertensive effect of betaxolol, a cardioselective beta-adrenoceptor antagonist, in renal hypertensive dogs. Nippon Yakurigaku Zasshi. 95:1990;355-360.
6. Bessho H., Suzuki J., Narimatsu A., Tobe A. Antihypertensive effect of betaxolol, a cardioselective beta-adrenergic antagonist, in experimental hypertensive rats. Nippon Yakurigaku Zasshi. 95:1990;347-354.
7. Bessho H., Suzuki J., Tobe A. Vasodilating actions of betaxolol, a cardioselective beta adrenoceptor antagonist, in isolated rat arteries. Jpn. J. Pharmacol. 55:1991;351-358.
8. Collignon-Brach J. Long-term effect of ophthalmic beta-adrenoreceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma. Curr. Eye Res. 11:1992;1-3.
9. Denis P., Elena P.P. Recepteurs beta-adrenergiques vasculaires retiniens chez l'homme. Ophthalmmologie. 3:1989;62-64.
10. S.M. Drance, J. Flammer, Some effects of antiglaucoma drugs on visual function, in: S.M. Drance, A.H. Neufeld (Eds.), Glaucoma: Applied Pharmacology in Medical Treatment, Grune and Stratton, Inc., Orlando, 1983, pp. 569-576.
11. Epstein D.L., Krug J.H., Hertzmark E., Remis L.L., Edelstein D.J. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology. 96:1991;1460-1467.
12. Flammer J., Robert Y., Gloor B. Influence of pindolol and timolol on the visual fields of glaucoma patients. J. Ocul. Pharm. 2:1987;305-311.
13. Gross R.L., Hensley S.H., Wu S.M. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of B-blockers. Surv. Ophthalmol. 43:1999;S162-S170.
14. Grunwald J.E. Effect of topical timolol in the human retinal circulation. Invest. Ophthalmol. Vis. Sci. 27:1986;1713-1719.
15. Grunwald J.E. Effect of timolol maleate on the retinal circulation of human eyes with ocular hypertension. Invest. Ophthalmol. Vis. Sci. 31:1990;521-526.
16. Haefliger I.O., Lietz A., Griesser S.M., Ulrich A., Schotzau A., Hendrickson P., Flammer J. Modulation of the Heidelberg Retinal Flowmeter parameter flow at the papilla of healthy subjects: effect of carbogen, oxygen, high intraocular pressure, and B-blockers. Surv. Ophthalmol. 43:1999;S59-S65.
17. A. Harris, J.A. Shoemaker, M. Weiland, L.E. Pillunat, W.E. Sponsel, The acute effects of betaxolol on perimacular hemodynamics, in: S.M. Drance (Ed.), Update for Glaucoma, Ocular Blood Flow and Drug Treatment, Kugler, Amsterdam, pp. 109-114.
18. Hester R.K., Chen Z., Becker E.J., McLaughlin M.A., DeSantis L. The vascular relaxant effects of betaxolol, carteolol, and timolol on potassium-induced tone in the porcine long posterior ciliary artery. Invest. Ophthalmol. Vis. Sci. 33(Suppl. P):1992;809.
19. Hoste A.M. In vitro studies of the effects of B-adrenergic drugs on retinal and posterior ciliary microarteries. Surv. Ophthalmol. 43:1999;S183-S190.
20. Kitaya N., Yoshida A., Ishiko S., Mori F., Abiko T., Ogasawara H., Kato Y., Nagaoka T. Effect of timolol and UF-021 (a prostaglandin-related compound) on pulsatile ocular blood flow in normal volunteers. Ophthal. Res. 29:1997;139-144.
21. Luebeck P., Orgul S., Gugleta K., Gherghel D., Gekkleva M., Flammer J. Effect of timolol on anterior optic nerve blood flow in patients with primary open-angle glaucoma as assessed by the Heidelberg Retina Flowmeter. J. Glaucoma. 10:2001;13-17.
22. Martin X.D., Rabineau P.A. Vasoconstrictive effect of topical timolol on human retinal arteries. Graefe's Arch. Clin. Exp. Ophthalmol. 227:1989;526-530.
23. Messmer C., Flammer J., Stumpfig D. Influence of betaxolol and timolol in the visual fields of patients with glaucoma. Am. J. Ophthalmol. 112:1991;678-681.
24. Nicolela M.T., Buckley A.R., Walman B.E., Drance S.M. A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels. Clin. Pharmacol. Ther. 61:1997;583-595.
25. Oruc S., Sener E.C. A comparative study on the effects of apraclonidine and timolol on the ophthalmic blood flow velocity waveforms. Int. Ophthalmol. 23:1999;69-73.
26. Osborne N.N., DeSantis L., Bae J.H., Ugarte M., Wood J.P.M., Nash M.S., Chidlow G. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp. Eye Res. 69:1999;331-342.
27. N.N. Osborne, J.P.M. Wood, G. Childlow, R. Casson, L. DeSantis, K.-G. Schmidt, Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma, Brain Res. Bull. 62 (2003) 525-528.
28. Schmetterer L., Strenn K., Findl O., Breiteneder H., Graselli U., Agneter E., Eichler H.G., Wolzt M. Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. Clin. Pharmacol. Ther. 61:1997;583-595.
29. Sponsel W.E. Quantification and monitoring of visual field defects and a prospective, randomized comparison of pilocarpine and timolol using computerized perimetry (summary). Surv. Ophthalmol. 33(Suppl.):1989;427-428.
30. Sponsel W.E., Dallas N.L., Burbridge L. Visual field survival: the response to timolol therapy in open-angle glaucoma. Br. J. Ophthalmol. 67:1983;220-227.
31. Sponsel W.E., Kaufman P.L., Blum F.G. Jr. Association of retinal capillary perfusion with visual status during chronic glaucoma therapy. Ophthalmology. 104:1997;1026-1032.
32. Sponsel W.E., Mensah J., Kiel J.W., Remky A., Trigo Y., Baca W., Friberg T. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye. Am. J. Ophthalmol. 130:2000;151-159.
33. Sponsel W.E., Terry S., Khuu H.D., Lam K.-W., Frenzel H. Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy. Surv. Ophthalmol. 43(Suppl.):1999;210-213.
34. Stewart R.H., Kimbrough R.L., Ward R.L. Betaxolol vs. timolol: a six-month double blind study. Arch. Ophthalmol. 104:1986;46-48.
35. Tamaki Y., Araie M., Tomita K., Nagahara M. Effect of betaxolol on tissue circulation in the human optic nerve. J. Ocul. Pharmacol. Ther. 15:1999;313-321.
36. Tomidokoro A., Araie M., Tamaki Y., Muta K. Effects of topical carteolol and timolol on tissue circulation in the iris and choroid. Curr. Eye Res. 18:1999;381-390.
37. Trew D.R., Smith S.E. Postural studies in pulsatile ocular blood flow. II. Chronic open angle glaucoma. Br. J. Ophthalmol. 75:1991;71-75.
38. Turacli M.E., Ozden R.G., Gurses M.A. The effect of betaxolol on ocular blood flow and visual fields in patients with normotension glaucoma. Eur. J. Ophthalmol. 8:1998;62-66.
39. Van Buskirk E.M., Bacon E.R., Farenbach W.H. Ciliary vasoconstriction after topical adrenergic drugs. Am. J. Ophthalmol. 109:1990;511-517.
40. Vogel R., Tipping M.S., Kulaga S., Clineschmidt C.M. Changing therapy from timolol to betaxolol: effect on intraocular pressure in selected patients with glaucoma. Arch. Ophthalmol. 107:1989;1303-1307.
41. Wolf S., Schulte K., Berg B., Bertram B., Reim M. Einfluss von beta-blockern auf die retinale hemodynamik. Doppelblindstudie bie gesunden. Klin. Mbl. Augenheilk. 195:1989;229-231.
42. 2+ entry blockers. Surv. Ophthalmol. 43:1999;S214-S222.
43. Zhau J., Mao J., Sui K. The effect of three kinds of anti-glaucoma eye drops on ocular blood flow. Chin. J. Ophthalmol. 36:2000;425.